Israel Englander’s Doximity DOCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-28,400
Closed -$1.26M 5856
2025
Q4
$1.26M Sell
28,400
-18,500
-39% -$1.04M ﹤0.01% 4316
2025
Q3
$3.43M Buy
46,900
+7,600
+19% +$496K ﹤0.01% 3524
2025
Q2
$2.41M Sell
39,300
-14,300
-27% -$798K ﹤0.01% 3720
2025
Q1
$3.11M Sell
53,600
-2,800
-5% -$177K ﹤0.01% 3345
2024
Q4
$3.01M Buy
+56,400
New +$2.76M ﹤0.01% 3305
2023
Q1
Sell
-10,000
Closed -$336K 6466
2022
Q4
$336K Buy
+10,000
New +$305K ﹤0.01% 5014

Other funds holding DOCS

Israel Englander's DOCS Position: Q2 2026 in Review

Israel Englander increased its Doximity (DOCS) stake by 361% in Q2 2026, buying an estimated $35.8M and bringing the position to 2,068,601 shares worth $42.9M. The position accounts for 0.02% of the portfolio, ranked #995.

Israel Englander first reported a position in DOCS in Q2 2021 and has held it in 17 quarters since. The position peaked at $48.3M in Q3 2025. 355 funds tracked by Wall St. Rank hold DOCS as of Q2 2026.

  • Israel Englander held 2,068,601 shares of Doximity worth $42.9M as of Q2 2026.
  • Israel Englander bought 1,619,819 Doximity shares in Q2 2026, an estimated $35.8M.
  • Doximity made up 0.02% of Israel Englander's portfolio in Q2 2026, its #995 holding.
  • Israel Englander first reported a position in Doximity in Q2 2021 and has held it in 17 quarters since.
  • Israel Englander's Doximity position peaked at $48.3M in Q3 2025.
  • 355 funds tracked by Wall St. Rank held Doximity as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.